Brazil
Medical device market intelligence for Brazil. Regulatory changes, competitor moves, and procurement trends.
Recent signals
A new device for vestibular evoked myogenic potential shows similar bioelectrical responses to the gold standard device.
The Canabrava Ring was evaluated for safety and efficacy in cataract surgery on small pupils in a completed study.
The L6R T-ONE SP NC ROTH .022 device by ID-LOGICAL is classified as Class IIa and registered in EUDAMED.
A study tested the DUDA Device to prevent cervical stenosis after conization in high-grade cervical dysplasia.
TOYO COMERCIO has registered a surgical instruments firm with FDA under product code HTE.
Ortho Pauher has registered a medical device with the FDA under product code KNO.
Indusbello Ind. e Com. de Prod. Med. e Odont. Ltda. registered a medical device with product code KCQ.
Study completed on using Occlutech Figulla ASD N for bronchopleural fistula closure via bronchoscopy.
Aditek do Brasil SA registered the KIT 5X5 EASYCLIP+ PASSIVE 018 MBT HK 3 W/20 as a Class IIA medical device.
Aditek do Brasil SA registered the KIT 5X5 EASYCLIP+ PASSIVE 018 MBT HK 3,4,5 W/20 as Class IIA device.
Aditek do Brasil SA registered the BRACKET EASYCLIP+ PASSIVE 018, classified as Class IIa medical device.
Aditek do Brasil SA registered the BRACKETEASYCLIP+ PASSIVE 018 device as Class IIA in EUDAMED.
A study is assessing a heart monitor's effectiveness post-myocardial infarction in patients over 18 years.
The article discusses the atmosphere around the Bragantino vs Palmeiras match amid a title chase.
Injuries may sideline key players like Yamal and Salah from the 2026 World Cup.
TECNOCIRURGICA has registered a medical device with the FDA under product code MDM.
Research priorities for surgical obstetrics and family planning in LMICs were established through expert consultation.
A quality improvement initiative in Brazil reduced maternal mortality by 34.2% through timely obstetric care.
WHO expands IVD prequalification to include rapid tests for TB diagnosis in vulnerable populations.
GBA1 is identified as a major Parkinson's disease risk factor in West Africa, highlighting global research collaboration.